Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, Revolution Medicines Inc (NASDAQ: RVMD) closed at $80.52 down -0.28% from its previous closing price of $80.75. In other words, the price has decreased by -$0.28 from its previous closing price. On the day, 1.8 million shares were traded. RVMD stock price reached its highest trading level at $80.925 during the session, while it also had its lowest trading level at $79.81.
Ratios:
For a deeper understanding of Revolution Medicines Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.05 and its Current Ratio is at 8.05. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In the most recent recommendation for this company, Wolfe Research on November 18, 2025, initiated with a Outperform rating and assigned the stock a target price of $75.
On November 03, 2025, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $77.
On October 21, 2025, Mizuho started tracking the stock assigning a Outperform rating and target price of $90.Mizuho initiated its Outperform rating on October 21, 2025, with a $90 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 16 ’25 when Cislini Jeff sold 2,688 shares for $76.82 per share. The transaction valued at 206,484 led to the insider holds 47,884 shares of the business.
GOLDSMITH MARK A sold 15,394 shares of RVMD for $1,182,526 on Dec 16 ’25. The insider now owns 232,469 shares after completing the transaction at $76.82 per share. On Dec 16 ’25, another insider, Kelsey Stephen Michael, who serves as the insider of the company, sold 5,447 shares for $76.82 each. As a result, the insider received 418,423 and left with 278,600 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVMD now has a Market Capitalization of 15566110720 and an Enterprise Value of 14049572864.
Stock Price History:
The Beta on a monthly basis for RVMD is 0.99, which has changed by 0.8461362 over the last 52 weeks, in comparison to a change of 0.17823458 over the same period for the S&P500. Over the past 52 weeks, RVMD has reached a high of $81.97, while it has fallen to a 52-week low of $29.17. The 50-Day Moving Average of the stock is 16.14%, while the 200-Day Moving Average is calculated to be 71.63%.
Shares Statistics:
For the past three months, RVMD has traded an average of 2.35M shares per day and 2747110 over the past ten days. A total of 189.71M shares are outstanding, with a floating share count of 165.32M. Insiders hold about 14.48% of the company’s shares, while institutions hold 88.61% stake in the company. Shares short for RVMD as of 1765756800 were 15070669 with a Short Ratio of 6.42, compared to 1763078400 on 17485484. Therefore, it implies a Short% of Shares Outstanding of 15070669 and a Short% of Float of 8.28.
Earnings Estimates
Revolution Medicines Inc (RVMD) is currently under the scrutiny of 14.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$1.65, with high estimates of -$1.38 and low estimates of -$1.8.
Analysts are recommending an EPS of between -$4.92 and -$5.76 for the fiscal current year, implying an average EPS of -$5.54. EPS for the following year is -$6.27, with 16.0 analysts recommending between -$4.49 and -$7.63.
